These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 22511072)
21. Overexpression of BRCA2 gene in sporadic breast tumours. Bièche I; Noguès C; Lidereau R Oncogene; 1999 Sep; 18(37):5232-8. PubMed ID: 10498873 [TBL] [Abstract][Full Text] [Related]
22. Increased expression of urokinase-type plasminogen activator mRNA determines adverse prognosis in ErbB2-positive primary breast cancer. Urban P; Vuaroqueaux V; Labuhn M; Delorenzi M; Wirapati P; Wight E; Senn HJ; Benz C; Eppenberger U; Eppenberger-Castori S J Clin Oncol; 2006 Sep; 24(26):4245-53. PubMed ID: 16963728 [TBL] [Abstract][Full Text] [Related]
23. Prognostic significance of RACGAP1 mRNA expression in high-risk early breast cancer: a study in primary tumors of breast cancer patients participating in a randomized Hellenic Cooperative Oncology Group trial. Pliarchopoulou K; Kalogeras KT; Kronenwett R; Wirtz RM; Eleftheraki AG; Batistatou A; Bobos M; Soupos N; Polychronidou G; Gogas H; Samantas E; Christodoulou C; Makatsoris T; Pavlidis N; Pectasides D; Fountzilas G Cancer Chemother Pharmacol; 2013 Jan; 71(1):245-55. PubMed ID: 23096218 [TBL] [Abstract][Full Text] [Related]
24. Effects of cell membrane phospholipid level and protein kinase C isoenzyme expression on hepatic metastasis of colorectal carcinoma. Li SY; Yu B; An P; Liang ZJ; Yuan SJ; Cai HY Hepatobiliary Pancreat Dis Int; 2004 Aug; 3(3):411-6. PubMed ID: 15313680 [TBL] [Abstract][Full Text] [Related]
25. MicroRNA-9 is associated with epithelial-mesenchymal transition, breast cancer stem cell phenotype, and tumor progression in breast cancer. Gwak JM; Kim HJ; Kim EJ; Chung YR; Yun S; Seo AN; Lee HJ; Park SY Breast Cancer Res Treat; 2014 Aug; 147(1):39-49. PubMed ID: 25086633 [TBL] [Abstract][Full Text] [Related]
26. Molecular genetics and structural genomics of the human protein kinase C gene module. Kofler K; Erdel M; Utermann G; Baier G Genome Biol; 2002; 3(3):RESEARCH0014. PubMed ID: 11897026 [TBL] [Abstract][Full Text] [Related]
27. [Cell membrane phospholipid variation and protein kinase C expression effects on hepatic metastasis of large intestinal carcinoma]. Li SY; Yu B; An P; Liang ZJ; Yuan SJ; Cai HY Zhonghua Wai Ke Za Zhi; 2004 Jan; 42(2):84-7. PubMed ID: 15009987 [TBL] [Abstract][Full Text] [Related]
28. Differential role of PKC isoforms in GnRH and phorbol 12-myristate 13-acetate activation of extracellular signal-regulated kinase and Jun N-terminal kinase. Dobkin-Bekman M; Rahamin-Ben Navi L; Shterntal B; Sviridonov L; Przedecki F; Naidich-Exler M; Brodie C; Seger R; Naor Z Endocrinology; 2010 Oct; 151(10):4894-907. PubMed ID: 20810567 [TBL] [Abstract][Full Text] [Related]
29. Differential subcellular expression of protein kinase C betaII in breast cancer: correlation with breast cancer subtypes. Gökmen-Polar Y; Mehta R; Tuzmen S; Mousses S; Thorat MA; Sanders KL; Turbin D; Leung S; Huntsman DG; Sledge GW; Badve S Breast Cancer Res Treat; 2010 Nov; 124(2):327-35. PubMed ID: 20099025 [TBL] [Abstract][Full Text] [Related]
30. Expression of protein kinase C gene family members is temporally and spatially regulated during neural development in vitro. Oehrlein SA; Maelicke A; Herget T Eur J Cell Biol; 1998 Dec; 77(4):323-37. PubMed ID: 9930657 [TBL] [Abstract][Full Text] [Related]
31. Significance of skp2 expression in primary breast cancer. Sonoda H; Inoue H; Ogawa K; Utsunomiya T; Masuda TA; Mori M Clin Cancer Res; 2006 Feb; 12(4):1215-20. PubMed ID: 16489076 [TBL] [Abstract][Full Text] [Related]
32. Protection of glioblastoma cells from cisplatin cytotoxicity via protein kinase Ciota-mediated attenuation of p38 MAP kinase signaling. Baldwin RM; Garratt-Lalonde M; Parolin DA; Krzyzanowski PM; Andrade MA; Lorimer IA Oncogene; 2006 May; 25(20):2909-19. PubMed ID: 16331246 [TBL] [Abstract][Full Text] [Related]
33. BCL2L12: a promising molecular prognostic biomarker in breast cancer. Tzovaras A; Kladi-Skandali A; Michaelidou K; Zografos GC; Missitzis I; Ardavanis A; Scorilas A Clin Biochem; 2014 Dec; 47(18):257-62. PubMed ID: 25230343 [TBL] [Abstract][Full Text] [Related]
34. Identification of a three-gene expression signature of poor-prognosis breast carcinoma. Bièche I; Tozlu S; Girault I; Lidereau R Mol Cancer; 2004 Dec; 3(1):37. PubMed ID: 15606925 [TBL] [Abstract][Full Text] [Related]
35. Total cyclooxygenase-2 mRNA levels correlate with vascular endothelial growth factor mRNA levels, tumor angiogenesis and prognosis in non-small cell lung cancer patients. Yuan A; Yu CJ; Shun CT; Luh KT; Kuo SH; Lee YC; Yang PC Int J Cancer; 2005 Jul; 115(4):545-55. PubMed ID: 15704107 [TBL] [Abstract][Full Text] [Related]
36. Detection of circulating cytokeratin-19 mRNA-positive cells in the blood and the mitotic index of the primary tumor have independent prognostic value in early breast cancer. Tryfonidis K; Kafousi M; Perraki M; Apostolaki S; Agelaki S; Georgoulias V; Stathopoulos E; Mavroudis D Clin Breast Cancer; 2014 Dec; 14(6):442-50. PubMed ID: 24958324 [TBL] [Abstract][Full Text] [Related]
37. Overexpression of protein kinase C epsilon in astroglial brain tumor derived cell lines and primary tumor samples. Sharif TR; Sharif M Int J Oncol; 1999 Aug; 15(2):237-43. PubMed ID: 10402232 [TBL] [Abstract][Full Text] [Related]
38. Overexpression of protein kinase Calpha mRNA may be an independent prognostic marker for gastric carcinoma. Lin KY; Fang CL; Uen YH; Chang CC; Lou HY; Hsieh CR; Tiong C; Pan S; Chen SH J Surg Oncol; 2008 May; 97(6):538-43. PubMed ID: 18314869 [TBL] [Abstract][Full Text] [Related]
39. Bone marrow cytokeratin 19 mRNA level is an independent predictor of relapse-free survival in operable breast cancer patients. Farmen RK; Nordgård O; Gilje B; Shammas FV; Kvaløy JT; Oltedal S; Heikkilä R Breast Cancer Res Treat; 2008 Mar; 108(2):251-8. PubMed ID: 17492378 [TBL] [Abstract][Full Text] [Related]
40. Expression of transferrin receptor and ferritin H-chain mRNA are associated with clinical and histopathological prognostic indicators in breast cancer. Yang DC; Wang F; Elliott RL; Head JF Anticancer Res; 2001; 21(1B):541-9. PubMed ID: 11299801 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]